GENE ONLINE|News &
Opinion
Blog

NASDAQ
Financial Times’ US Pharma Biotech Summit 2022: Track & Invest in American Life Sciences
2022-05-16
Top 10 Biotech IPOs on NASDAQ in 2021
2022-01-19
Cue Health’s $200 Million Nasdaq IPO: Where Will the Ball Roll Next?
2021-09-27
Citius Pharma Makes Calculated Market Moves with Phase 3 Results Looming for Potential Blockbuster Product
2021-02-21
Proteomics Company Nautilus Bio to List on NASDAQ via SPAC
2021-02-12
IPO
Vor BioPharma Surpasses $1 Billion Valuation After IPO
2021-02-07
Spotlight: The Rise of the SPAC in Biotech
2021-01-06
Cambridge Startup’s Take Two at Public Debut is Off to a Slow Start
2020-10-18
CureVac Shares Catapult 494% Following Successful IPO Debut
2020-08-18
Base Editing Start-up Beams with US$180 Million IPO
2020-02-06
LATEST
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
Pharmacogenomics in Asia-Pacific: Nalagenetics CEO Levana Sani Offers Insights and Strategies
2024-04-17
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top